In a randomized trial conducted in Africa, deferring antiretroviral therapy initiation for 5 weeks after diagnosis of meningitis was associated with significantly improved survival.
Increasingly, studies have suggested benefit from early initiation of antiretroviral therapy (ART) after diagnosis of an opportunistic infection, including tuberculosis (NEJM JW AIDS Clin Care Jun 22 2009). However, early ART is seemingly not beneficial for patients with tuberculous meningitis, and the evidence remains mixed for those with cryptococcosis. In a recent trial conducted in Uganda and South Africa, researchers investigated the timing of ART initiation in HIV-infected patients with cryptococcal meningitis.
The 177 participants received induction therapy with 2 weeks of amphotericin B and high-dose fluconazole, followed by consolidation therapy with fluconazole. After 7 to 11 days of antifungal treatment, they were randomized to re…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)